Related Experiment Video
Updated: Jun 16, 2026
04:56
Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
Coagulation in pregnancy
Patrick Thornton1, Joanne Douglas
1Department of Anesthesia, University of British Columbia, BC Women's Hospital, Vancouver, Canada.
Best Practice & Research. Clinical Obstetrics & Gynaecology
|January 26, 2010
Summary
Pregnancy significantly alters the coagulation system. Understanding these changes is crucial for managing pregnant patients, especially those with rare blood disorders, due to limited clinical guidance.
Area of Science:
- Obstetrics
- Hematology
- Anesthesiology
Background:
- Pregnancy involves dynamic alterations in the coagulation system.
- Managing parturients with pre-existing hematological conditions presents unique challenges.
- Limited data exists for guiding obstetric and anesthetic care in these complex cases.
Purpose of the Study:
- To highlight the critical changes in the coagulation system during pregnancy.
- To emphasize the importance of understanding these hematological shifts for clinical practice.
- To address the knowledge gap in managing rare hematological conditions in parturients.
Main Methods:
- Review of current literature on coagulation physiology in pregnancy.
- Analysis of clinical guidelines and case reports concerning hematological disorders in parturients.
- Synthesis of information to inform obstetric and anesthetic management strategies.
Main Results:
- Pregnancy-induced coagulation changes require careful consideration.
- Pre-existing rare hematological conditions complicate parturient management.
- Evidence-based guidance for these specific scenarios is often scarce.
Conclusions:
- Clinicians must possess a thorough understanding of pregnancy-related coagulation changes.
- Specialized knowledge is essential for the safe obstetric and anesthetic care of parturients with hematological conditions.
- Further research is needed to develop comprehensive management protocols for rare hematological disorders during pregnancy.
Related Concept Videos
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...